- Home
- ROOT vs PRME Comparison
ROOT vs PRME Comparison
Compare ROOT & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.01
Company Overview
Basic Information| Metric | ROOT | PRME |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 804.6M | 666.1M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ROOT | PRME |
|---|---|---|
| Price | $48.22 | $4.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $108.40 | $6.42 |
| AVG Volume (30 Days) | 365.8K | ★ 2.6M |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.96 | 18.18 |
| EPS | ★ 2.36 | N/A |
| Revenue | ★ $1,517,100,000.00 | $4,632,000.00 |
| Revenue This Year | $10.08 | $15.20 |
| Revenue Next Year | $12.63 | $316.23 |
| P/E Ratio | $20.39 | ★ N/A |
| Revenue Growth | 28.95 | ★ 55.28 |
| 52 Week Low | $46.63 | $1.11 |
| 52 Week High | $181.14 | $6.94 |
Technical Indicators
Market Signals| Indicator | ROOT | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 33.14 | 52.97 |
| Support Level | N/A | $3.19 |
| Resistance Level | $88.63 | $4.04 |
| Average True Range (ATR) | 3.47 | 0.29 |
| MACD | -0.73 | 0.05 |
| Stochastic Oscillator | 10.82 | 54.03 |
Price Performance
Historical Comparison ROOT
PRME
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.